NABL, CAP, ISO
What is DCT?
The Direct Coombs test is a blood test which detects if you have antibodies in your blood that are making your immune system attack and ruin your own red blood cells. If present, antibodies against RBCs will target and destroy foreign RBCs acquired through blood transfusions, or those present in a fetus by the antibodies of the mother.
Why is DCT done?
- To screen the recipient of a blood transfusion before the transfusion is done
- To screen the mother’s blood for antigens that can target the RBCs of the newborn
- To detect type of anemia
- To diagnose hemolytic anemia and evaluate if it is caused by autoimmune disease or induced by drugs
Preparation for DCT
- No special preparation required
Sample Type for DCT
The sample type collected for Coombs Test - Direct is: Blood
Diagno Labs, established in the year 2012, is uniquely positioned to more effectively support local pathology for enhanced patient care. Diagno Labs, with complementary areas of expertise and service offerings, allows us to build on the company's leadership positions, provide access to medical and scientific expertise, expand geographical presence to better serve customers and emerge as the most valued company in the healthcare industry. Our Parent group RJ Corp is a well-diversified Indian MNC,with an annual turnover of over 15 billion rupees. Established in the 1990s, RJ Corp has achieved heights of success under the dynamic leadership and guidance of its founder-chairman Mr. Ravi Kant Jaipuria. The group has diversified business interests in beverages, breweries, real estate, hospitality, healthcare, education, dairy, food service and retail. Our network company, Cryobanks International India, is a leader in the collection, processing and banking of umbilical cord blood stem cells.